First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Department of Medical Oncology, Specialized Hospital for Active Treatment of Oncological Diseases, Sofia

Department of Medical Oncology, Complex Oncology Center, Veliko Tarnovo

Medical Oncology Clinic, Multiprofile Hospital for Active Treatment, Varna

Public Institution: Dnipropetrovsk City Multispeciality Clinical Hospital #4, Dnipropetrovsk

Public Healthcare Instituion: Kharkiv Regional Clinical Oncology Center, Kharkiv

Kansas City Cancer Center, Kansas City

Ivano-Frankivsk Regional Oncology Center, Ivano-Frankivsk

Public Clinical Treatment and Prophylaxis Instituion: Donetsk Regional Antitumor Center, Donetsk

Zakarpattia Regional Clinical Oncology Center, Uzhhorod

Desert Hematology Oncology Medical Group, Inc., Rancho Mirage

Non-State Medical Institution: Central Clinical Hospital #2, Moscow

State Medical Institution: Arkhangelsk Regional Clinical Oncology Center, Arkhangelsk

St. Petersburg State Healthcare Institution: City Clinical Oncology Center, Saint-Pertersburg

State Medical Instituion Kursk Regional Oncology Center, Kursk

Curie Manavata Cancer Centre, Nashik

Noble Hospital, Pune

State Therapeutical and Prophylatic Institution: Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk

NIZAM's Institute of Medical Sciences, Hyderabad

Dr. Kamakshi Memorial Hospital, Chennai

G Kuppuswamy Naidu Memorial Hospital, Valvadi Narayanaswamy Cancer Centre, Coimbatore

Orchid Nursing Home, Kolkata

Hackensack University Medical Center, Hackensack

M S Patel Cancer Centre, Shree Krishna Hospital, Anand

Shatabdi Super Speciality Hospital, Nashik

Instituto Nacional de Cancerologia, Mexico City

Kyiv City Clinical Oncology Center, Kyiv